Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine.Moderna's Spikevax KP.2 targets the KP.2 variant of the virus.The U.S. Food and Drug Administration has also approved the shot,
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024." The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians
Moderna Gets Canada Approval for Updated Covid-19 Vaccine
The biotechnology company on Tuesday said that Health Canada authorized the vaccine targeting the KP.2 Covid-19 variant of Sars-Cov-2. Moderna will begin delivery of updated doses to the Public Health Agency of Canada,
1d
on MSN
Be warned: Check your insurance before getting a COVID-19 vaccine this year
The Centers for Disease Control and Prevention says that the Food and Drug Administration has ended a program that provided ...
1d
on MSN
Latest COVID variant, XEC, has spread to half of US states, reports say
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
2d
Moderna: Still Bullish View
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
6d
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
9d
on MSN
Moderna lays out plan to slice research and development spending
Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...
Medscape
1d
EU OKs Meningococcal Disease Vaccine
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
9d
on MSN
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
The News Leader
19d
2024-2025 COVID-19 vaccines now available at GIANT and MARTIN'S pharmacies
Moderna’s
Spikevax
and Pfizer’s Comirnaty are available at GIANT and MARTIN’S pharmacies — inventory may vary by location. Vaccines for those 12 years and older are readily available. Vaccines for ...
18d
on MSN
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
For the first time in the U.K., the updated vaccine,
Spikevax
JN.1, will also be available to purchase privately for those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Moderna
COVID-19
Feedback